RecruitingNCT04664556
National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns
Population-based Nationwide Study on Invasive Pneumococcal Infections Among Children (0-18 Years) in France
Sponsor
Association Clinique Thérapeutique Infantile du val de Marne
Enrollment
2,500 participants
Start Date
Dec 13, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.
Eligibility
Min Age: 1 DayMax Age: 18 Years
Inclusion Criteria1
- Isolate of Streptococcus pneumoniae from at least one blood culture, or pleural fluid, or joint fluid, or cerebrospinal fluid or other normally sterile body site, or if there is a positive blood polymerase chain reaction (PCR).
Exclusion Criteria1
- Pneumococcal strain not transmetted to National Reference Center for Pneumococci or to Regional Pneumococci Observatory
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04664556
Related Trials
ICU Background Early Awareness for Critical deterioratiON
NCT071194111 location
100-Year Human Aging Study
NCT075637771 location
Human Observatory Study
NCT076467821 location
MOTORCYCLE THORACIC TRAUMA SEVERITY SCORE: A NEW TRAUMA SEVERITY SCORE
NCT075822631 location
Factor Associated With Mortality in the ICU
NCT072497491 location